The role of facemasks and hand hygiene in the prevention of influenza transmission in households: results from a cluster randomised trial; Berlin, Germany, 2009-2011 by Suess, Thorsten et al.
RESEARCH ARTICLE Open Access
The role of facemasks and hand hygiene in the
prevention of influenza transmission in
households: results from a cluster randomised
trial; Berlin, Germany, 2009-2011
Thorsten Suess
1*, Cornelius Remschmidt
1, Susanne B Schink
1, Brunhilde Schweiger
2, Andreas Nitsche
3,
Kati Schroeder
3, Joerg Doellinger
3, Jeanette Milde
2, Walter Haas
1, Irina Koehler
1, Gérard Krause
1 and
Udo Buchholz
1
Abstract
Background: Previous controlled studies on the effect of non-pharmaceutical interventions (NPI) - namely the use
of facemasks and intensified hand hygiene - in preventing household transmission of influenza have not produced
definitive results. We aimed to investigate efficacy, acceptability, and tolerability of NPI in households with influenza
index patients.
Methods: We conducted a cluster randomized controlled trial during the pandemic season 2009/10 and the
ensuing influenza season 2010/11. We included households with an influenza positive index case in the absence of
further respiratory illness within the preceding 14 days. Study arms were wearing a facemask and practicing
intensified hand hygiene (MH group), wearing facemasks only (M group) and none of the two (control group).
Main outcome measure was laboratory confirmed influenza infection in a household contact. We used daily
questionnaires to examine adherence and tolerability of the interventions.
Results: We recruited 84 households (30 control, 26 M and 28 MH households) with 82, 69 and 67 household
contacts, respectively. In 2009/10 all 41 index cases had a influenza A (H1N1) pdm09 infection, in 2010/11 24 had
an A (H1N1) pdm09 and 20 had a B infection. The total secondary attack rate was 16% (35/218). In intention-to-
treat analysis there was no statistically significant effect of the M and MH interventions on secondary infections.
When analysing only households where intervention was implemented within 36 h after symptom onset of the
index case, secondary infection in the pooled M and MH groups was significantly lower compared to the control
group (adjusted odds ratio 0.16, 95% CI, 0.03-0.92). In a per-protocol analysis odds ratios were significantly reduced
among participants of the M group (adjusted odds ratio, 0.30, 95% CI, 0.10-0.94). With the exception of MH index
cases in 2010/11 adherence was good for adults and children, contacts and index cases.
Conclusions: Results suggest that household transmission of influenza can be reduced by the use of NPI, such as
facemasks and intensified hand hygiene, when implemented early and used diligently. Concerns about
acceptability and tolerability of the interventions should not be a reason against their recommendation.
Trial registration: The study was registered with ClinicalTrials.gov (Identifier NCT00833885).
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Since 2006, the World Health Organisation (WHO) and
other organisations have highlighted the need for con-
trolled trials to assist in formulating recommendations
on the use of non-pharmaceutical interventions (NPI) -
such as facemasks or hand hygiene measures - as
options to prevent influenza transmission, particularly in
households [1,2]. As these measures are easily applicable
and accessible for the general population and do not
rely on microbiological data they could be available even
in very early stages of a pandemic. Several controlled
trials testing NPI have lately been undertaken in differ-
ent settings and with different designs [3-7] but have
not been able to provide conclusive results. Four of
these studies were conducted within households [4-7],
one among adults living in university residence halls [3].
All but one [7] took place during seasonal influenza epi-
demics. Regarding interventions, one study compared
facemasks to respirators [6], another evaluated face-
masks only [4], while three studies assessed facemasks,
and/or hand hygiene measures in various combinations
[3,5,7].
In intention-to-treat analysis, none of the four
household based trials was able to show significant
reductions in secondary attack rates (SAR) when com-
paring intervention to control groups. However, one
subgroup-analysis (restricting intervention households
to those where intervention started within 36 h of
symptom onset) [5] and one per-protocol analysis [6]
showed significant effects of the interventions. Simi-
larly, cumulative incidence in the study among univer-
sity students yielded no significant differences between
study arms, but survival analysis identified significant
reductions of influenza-like-illness (ILI) in weeks 4-6
after recruitment [3].
In all publications, it was hypothesized that the effect
of interventions may be more pronounced in the case of
an influenza pandemic, due to higher public anxiety
with resulting higher rates of adherence. This was sup-
ported by observations made in a comparable crisis,
namely the SARS epidemic [8].
During the pandemic of influenza A (H1N1)pdm09
there was a considerable amount of uncertainty among
public health officials if or which NPI should be recom-
mended. Germany, in accordance with many other
countries, did not encourage the widespread use of face-
masks; hand washing had been generally recommended
against the transmission of respiratory viruses already
before the pandemic. Further evidence based data on
NPI from controlled studies are still needed, as they are
necessary to inform decision makers on the potential
benefit of NPI in influenza pandemics.
Between 2009 and 2011 we conducted a cluster rando-
mised trial on the efficacy, adherence and tolerability of
facemasks and intensified hand hygiene to prevent influ-
enza transmission in households. Study results from the
2009/2010 pandemic season concerning data about
adherence and tolerability only have already been pub-
lished [9].
Methods
Design
We conducted the study during two consecutive influ-
enza seasons (November 2009-January 2010 and Janu-
ary-April 2011) in Berlin, Germany. Index patients were
recruited by general practitioners or pediatricians. We
cooperated with 20 study sites in 2009/10 and 12 study
sites in 2010/11 evenly distributed in the city of Berlin.
We included index patients if they presented at the
study sites within 2 days of symptom onset, had a posi-
tive rapid antigen test for influenza (later to be con-
firmed by quantitative Reverse Transcription Polymerase
Chain Reaction [qRT-PCR]), and were at least 2 years
old. Index cases also had to be the only household
member suffering from respiratory disease within 14
days prior to symptom onset. Exclusion criteria were
pregnancy, severely reduced health status and HIV
infection. One person households were also not eligible
for inclusion.
Informed consent
We obtained written informed consent from all study
participants. If these were less than 18 years of age we
asked their parents or legal guardians to provide proxy
written consent, with additional written consent from
those participants aged 14 to 18 years of age. Children
were defined as persons aged less than 14 years, adults
were at least 14 years old.
Randomisation and blinding
We used a cluster randomisation with the households
serving as clusters. We prepared lists of random num-
bers with Microsoft Excel 2003 (Mircosoft™ Coopera-
tion, Seattle, USA) which were divided between the
three intervention groups. Each participating physician
received a list of random numbers with the interven-
tions represented in a 1:1:1 ratio. Eligible index patients
were randomly assigned a number, which was then
communicated to the study center. The resulting inter-
vention was only communicated to the households with
the physicians (as well as laboratory personnel) blinded
from the randomisation results. Intervention material
was given to the study sites in closed boxes marked only
with the randomisation number. Recruiting physicians
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interventions and the boxes for the three intervention
arms looked identical. After randomisation, participants
were given their box by the physician’s assistants.
Interventions
T h ef o l l o w i n gt h r e ei n t e r v e n t i o ng r o u p sw e r eu s e d :( i )
Mask/Hygiene (MH) arm: households were provided
with alcohol based hand-rub (Sterilium™, Bode Chemie,
Germany) and surgical facemasks in two different sizes,
one for children aged younger than 14 years (Child’s
Face Mask, Kimberly-Clark, USA) and one for adults
(Aérokyn Masques, LCH Medical Products, France). If
masks intended for participants younger than 14 years
did not fit properly (as assessed by study personnel dur-
ing the first household visit), we asked them to wear
adult masks instead. Household also received informa-
tion on the proper use of the interventions; (ii) Mask
(M) arm: we provided the household with surgical face-
masks and information on their correct use; (iii) Control
(C) arm: no masks or hand rub was provided. All parti-
cipating households received general written information
on infection prevention [10]. Households received all
necessary material (including a digital tympanic thermo-
meter) on the day of recruitment and were called by
study personnel immediately after leaving the study sites
for instructions on how to use it correctly (provisional
implementation of the intervention). Trained study per-
sonnel visited the household no later than 2 days after
symptom onset of the index case. Using written infor-
mation, study personnel demonstrated the correct use of
the intervention material (full implementation of the
intervention). We asked participants of the MH group
to always use the provided hand rub after direct contact
with the index patient (or other symptomatic household
members), after having touched household items being
used by the index patients and/or other symptomatic
household contacts, as well as after coughing/sneezing,
before meals, before preparing meals and when return-
ing home. We asked all participants of the MH and M
groups to wear masks at all times when the index
patient and/or any other household member with
respiratory symptoms were together in one room with
healthy household members. Facemasks were to be
changed regularly during the day and not to be worn
during the night or outside the household.
Follow up
The observation period for each household lasted 8
days, starting on the day of symptom onset of the index
patient (day 1). We visited households on days 2, 3, 4, 6,
and 8 (five times) or on days 3, 4, 6 and 8 (four times)
depending on the day of recruitment. During these visits
we obtained nasal wash specimens (or - if these were
not possible - nasal swabs) from all participating house-
hold members. Antiviral medication was given to index
patients and secondary cases by their individual physi-
cians based on their clinical evaluation independent of
study procedures. By definition, a “timely” antiviral ther-
apy started within 2 days of symptom onset.
When household members developed fever (> 38.0°
C), cough, or sore-throat they were asked to adopt the
same preventive behaviour as the index patient (i.e. use
facemasks or hand hygiene measures as required by
index patients to protect other healthy household
members) until the end of the observation period. All
participants self-recorded symptoms (fever, shivering,
measured temperature, cough, sore throat) and daily
routines (incl. the time spent at home, and within close
range (i.e. < 2 m) of the index patient) in a daily moni-
toring questionnaire.
Outcome definitions
The primary outcome measure for secondary cases was
qRT-PCR confirmed influenza infection. We defined a
symptomatic secondary influenza virus infection as a
laboratory confirmed influenza infection in a household
member who developed fever (> 38.0°C), cough, or sore-
throat during the observation period. We termed all
other secondary cases as subclinical. A secondary out-
come measure was the occurrence of ILI as defined by
WHO [11] as fever plus cough or sore throat.
Adherence
Participants of the M and MH groups also recorded
daily adherence with facemasks, i.e. if they wore masks
“always”, “mostly”, “sometimes”,o r“never” in the situa-
tion they had been asked to wear them. In the season
2010/11 they also recorded the number of masks used
per day. Participants of the MH households additionally
noted the number of hand disinfections per day. On day
nine, study personnel conducted an exit questionnaire
with all participants collecting information on (preven-
tive) behaviour during the past 8 days, general attitudes
towards NPI, the actual amount of used intervention
materials and - if applicable - problems with wearing
facemasks. We did not address potential problems with
intensified hand hygiene. Parents answered the question-
naires on behalf of their children.
For the final analysis, two definitions of adherence
were used, the first based on daily observations, the sec-
ond on the behaviour of participants during the five
consecutive days after implementation.
Used intervention material per household member was
calculated by dividing the amount used per household
by the number of household members.
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Participants received a reimbursement of €150 for the
large number of respiratory samples obtained.
Sample collection and laboratory methods
For the collection of nasal wash, we used 5 mL of iso-
tonic saline, which were instilled into one nostril with
participants heads tilted backwards. Participants were
asked to remain in this position for 10-15 s while mak-
ing hard ‘K’ sounds without swallowing. Subsequently,
the participants were told to tilt their heads forward and
the fluid was collected in a sterile cup [12]. Nasal swabs
were collected by using virus transport swabs (Mastas-
wab™; MAST Diagnostica, Reinfeld, Germany). Samples
were stored refrigerated (at a temperature of approxi-
mately 5°C) before analysis [13]. Specimens were ana-
lysed by qRT-PCR at the Centre for Biological Security,
Division of Highly-Pathogenic Viruses (season 2009/10)
and the National Reference Centre for Influenza (season
2010/11) both part of the Robert Koch Institute in Ber-
lin, Germany. RNA was extracted using either the
MagNA Pure 96 DNA and Viral Nucleic Acid Small
Volume Kit (Roche Applied Science, Mannheim, Ger-
many) on MagNA Pure 96 instrument (Roche Applied
Science) according to the manufacturer’s instructions.
Details about the PCR protocol as well as primer and
probe sequences have been published elsewhere [14].
Sample size estimation and statistical analysis
We assumed a SAR of laboratory confirmed infection of
20% in household contacts of the control group, based
on data from another study of this group (SAR 26% [13])
as well as other published data on seasonal (18.4% [6])
and pandemic influenza (14.5% [15], 30% [16]). Assuming
an average of 2 household contacts per household [13]
and an intracluster correlation coefficient (ICC) of 0.3
[4-6], we estimated that 114 household members would
be needed in each intervention arm to detect a 75% dif-
ference in secondary attack rates, i.e. 20% in the control
group and 5% in the intervention groups, with 80%
power and at a significance level of 5%.
Analysis was done by intention-to-treat. For descrip-
tive analysis we used Student’s t-test and Kruskal-Wallis
one-way analysis of variance for numerical and chi-
square tests for categorical variables. The intention-to-
treat analysis was conducted in the following order:
1. Comparison of SAR between intervention groups via
adjusted chi-square tests [17] (overall and stratified by
virus subtype, season and time of implementation of
intervention) to account for the cluster design of the
study. We used a cluster bootstrapping technique for the
calculation of 95% confidence intervals (95% CI) [18].
2. We used the generalized estimating equations
(GEE) approach to fit logistic regression models [19] for
evaluation and comparison of SAR between intervention
groups. First, we calculated odds ratios (OR) for the out-
come “laboratory confirmed influenza” with the follow-
ing independent variables: (i) intervention group, (ii)
intervention group (with pooled data of M and MH
group), (iii) one separate model for each individual vari-
able that may have influenced household transmission
of influenza (i.e. age, sex, timely antiviral therapy of the
index, vaccination of household contacts, etc.) adjusted
for intervention group. This corresponds to a univari-
able analysis with the exception of the adjustment for
intervention group.
3. Calculation of ORs for the clinical case definition
(otherwise as in 2.).
4. Calculation of ORs for the outcome “laboratory
confirmed influenza” to analyse the effect of the inter-
ventions while adjusting for variables with possible influ-
ence on influenza transmission. In a further model we
used the variable intervention group with pooled data of
M and MH group.
5. Calculation of ORs for the outcome “laboratory
confirmed influenza” adjusting for variables with possi-
ble influence on influenza transmission in the following
subgroups: (i) only data from season 2009/10, (ii) only
data from season 2010/11, (iii) only data from house-
holds with full implementation of intervention < 36 h
after symptom onset of the index case, (iv) only data
from influenza A(H1N1)pdm09 cases.
We used a forced-entry method adjusting for variables
potentially associated with risk of secondary infection.
Sample sizes for these subgroup analyses were small and
sometimes did not allow the inclusion of the full list of
variables.
The per-protocol-analysis was conducted in the same
way as the intention-to-treat analysis but only with data
from participants who had followed the assigned
interventions.
For all analyses, we used two-sided tests and consid-
ered p-values of < 0.05 as significant. We performed
analyses with Stata software version 11 (Stata Corpora-
tion, Texas, USA).
Ethics statement and trial registration
Ethics Committee approval was obtained from the insti-
tutional review board of Charité Universitätsmedizin
Berlin. The study was registered with ClinicalTrials.gov
(Identifier NCT00833885).
Results
Participants
Initially, we recruited 111 households which were rando-
mised into one of the three intervention groups during
the two study periods in 2009/10 and 2010/11 (Figure
1). After application of the exclusion criteria 30, 26 and
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groups for analysis. The total number of study partici-
pants was 302, of whom 84 were index patients and 218
household contacts. The study flow according to the
CONSORT guidelines is shown in Figure 1.
Table 1 shows the baseline characteristics of index
patients and household contacts of all analyzed house-
holds stratified by season of study participation and
intervention group. One difference between the two
study seasons was that in 2009/10 all viruses belonged
to A (H1N1) pdm09, while in 2010/11 both A (H1N1)
pdm09 as well as B viruses circulated (p = 0.14 for com-
parison within season). Another difference is that - com-
pared to 2009/10 - the number of index patients
receiving timely antiviral therapy was significantly higher
in 2010/11 (p < 0.001). Furthermore, in 2010/11 a sig-
nificantly larger number of both index patients (p =
0.045) and household contacts (p = 0.003) was vacci-
nated compared to 2009/10. Finally, in 2009/10 rando-
misation occurred significantly earlier after symptom
onset compared to 2010/11 (p = 0.004) and a higher
proportion of households was visited by study personnel
within 36 h (p = 0.04). All other variables did not differ
significantly between the two study seasons (Table 1).
Secondary attack rates (SAR)
Overall, there were 35 (16%) secondary cases of qRT-
PCR confirmed influenza and 26 (12%) secondary ILI
out of a total of 218 household contacts belonging to 84
households. Secondary laboratory confirmed cases
occurred in 26 households, including 18 (69%) house-
holds with one secondary case, six (22%) with two sec-
ondary cases, and two (8%) with three secondary cases.
When stratified by season, overall SAR was 13% (14/
106) in 2009/2010 and 19% (21/112) in 2010/2011 (p =
0.3). For laboratory-confirmed cases SAR were not sig-
nificantly lower in the M (9% (6/69)) and MH group
(15% (10/67)) compared to the control group (23% (19/
82); Table 2). In all stratified analyses (by influenza type,
season, and implementation within 36 h after symptom
onset) SAR of the M group was approximately reduced
by 50% compared to the control group. In 2010/11 the
MH group had markedly different SAR in A (H1N1)
pdm09 households compared to B households. In A
(H1N1) pdm09 households, SAR was highest in the con-
trol group and similarly low in the MH and M groups;
but in B households it was highest in the MH group.
When considering only households with early “full
implementation” of the intervention (within 36 h after
symptom onset), SAR of the MH group was substan-
tially lower than in the control group.
SAR measured by the ILI case definition yielded
somewhat lower results compared to those using the
laboratory case definition, because not all laboratory-
confirmed cases were also ILI cases.
Overall, differences in SAR were not significant,
neither for laboratory confirmed secondary cases nor for
ILI (Table 2), neither in primary analysis nor after strati-
fication for season, influenza virus (sub)type or timing of
the first household visit (Table 2).
Multivariable and other analyses
In addition to the analysis of all three interventions
groups, we also calculated odds ratios (OR) for second-
ary infection when intervention (i.e. M- and MH-group)
groups were combined (Table 3). Although OR sug-
gested a protective effect, this was not statistically signif-
icant. Among other individual variables with possible
influence on secondary infection (such as sex, age, time
spent at home, timely antiviral therapy of the index
patient, and vaccination of the household contact) one
variable stood out: Household members who spent at
least 18 h of the day at home were significantly more
likely to develop laboratory confirmed influenza infec-
tion (or ILI) compared to those who spent less time at
home (Table 3).
In a subgroup analysis, we examined the effect of the
interventions only in households with early full imple-
mentation, and secondly only in households with (pan-
demic) A (H1N1) pdm09 infection. The first analysis
was carried out in a subset of households where the
intervention had been implemented no later than 36 h
after symptom onset of the index patient. In this subset
of 60 household contacts, we found a borderline signifi-
cant protective effect of the MH intervention against
laboratory confirmed influenza infection compared with
the control group after adjustment for potential
111 households randomised 
Mask & Hygiene 
Group (n=39) 
Mask Group
(n=37)
Control Group
(n=35)
Excluded (n=5)
- symptom onset > 2d (n=2) 
- co-infection (n=3)
Excluded (n=11) 
- negative influenza PCR (n=2) 
- declined to participate (n=2) 
- unresolved custody (n=1) 
- co-infection (n=6)
Excluded (n=11) 
- co-infection (n=4) 
- declined to participate (n=2) 
- symptom onset > 2d (n=4) 
- pregnancy  (n=1)
Analysed
n = 30 
n Index=30; n Contacts=82 
Analysed
n = 26 
n Index=26; n Contacts=69 
Analysed
n = 28 
n Index=28; n Contacs=67 
Figure 1 Study flow diagram.
Suess et al. BMC Infectious Diseases 2012, 12:26
http://www.biomedcentral.com/1471-2334/12/26
Page 5 of 16confounders (adjusted OR = 0.13; 95% CI = 0.01-1.28;
p = 0.08; Table 4). After pooling the M and MH group,
this effect became statistically significant (adjusted OR =
0.16; 95% CI = 0.03-0.92; p = 0.04). Among households
with index cases infected with A (H1N1)pdm09 (162
household contacts) OR for a secondary laboratory con-
firmed infection were significantly lower in the MH
group alone as well as the combined M- & MH-groups.
Results of subgroup analyses using ILI as outcome were
comparable to those using laboratory confirmed cases,
but none were statistically significant.
Considering that not all study participants followed the
intended intervention in the group that they were
assigned to, we conducted a (per-protocol) analysis
among all participants who fully adhered to the study
protocol. Because we implemented two interventions
(facemask use and intensified hand hygiene) it was possi-
ble that one person adhered to one intervention, but not
to the other. We therefore considered only adherence to
facemask use for this analysis. We excluded participants
of the control group when they wore a facemask during
the study period, and we excluded participants from the
M and MH group when they reported not wearing masks
at all throughout the study. Apart from these exclusions
of non-adherent study participants, we conducted the
same analyses as for the intention-to-treat analysis. All
OR of the M and MH group were below 1, mostly
between 0.2 and 0.3 relating to a protective effect of
70%-80% for the interventions (Table 5). Significant
results were reached in the M group when analysing the
complete data set and in the M as well as the MH group
when considering only A(H1N1)pdm09 households.
Table 1 Baseline characteristics of index patients and household contacts, stratified by season and intervention group
Variable 2009/2010 2010/2011
Control Group Mask Group Mask &
Hygiene Group
Control Group Mask Group Mask &
Hygiene Group
Index Cases - n 13 11 17 17 15 11
Influenza virus subtype:
A(H1N1)pdm09 - n/n (%) 13/13 (100) 11/11(100) 17/17 (100) 8/17 (47) 11/15 (73) 5/11 (45)
B - n/n (%) 0 0 0 10/17 (53) 4/15 (27) 6/11 (55)
Age (years) - median (IQR) 8 (7-10) 7 (5-10) 7 (4-10) 8 (6-11) 8 (4-9) 7 (5-9)
Age < 14 years - n/n (%) 12/13 (92) 11/11(100) 16/17 (94) 17/17 (100) 14/15 (93) 11/11 (100)
Sex male - n/n (%) 5/13 (39) 5/11 (45) 10/17 (59) 13/17 (77) 10/15 (67) 7/11 (64)
Vaccinated* - n/n (%) 0 0 0 2/17 (12) 2/15 (13) 0
Antiviral Therapy** - n/n (%) 3/13 (23) 0 2/17 (12) 11/17 (65) 11/15 (73) 10/11 (91)
Chronic Illness - n/n (%) 1/12 (8) 1/11 (9) 0 4/17 (24) 2/15 (13) 0
Symptoms:
Fever/Chills - n/n (%) 13/13(100) 11/11(100) 17/17(100) 17/17(100) 15/15(100) 11/11(100)
Cough - n/n (%) 12/13 (92) 11/11(100) 16/17 (94) 16/17 (94) 14/15 (93) 10/11 (91)
Sore Throat - n/n (%) 4/13 (31) 6/11 (55) 9/17 (53) 10/17 (59) 9/15 (60) 7/11 (64)
Myalgia - n/n (%) 11/13 (85) 9/11 (82) 11/17 (65) 14/17 (82) 14/15 (93) 9/11 (82)
Symptom onset to rando-misation (hours) -
mean ± SD
23.1 (3.7) 27.5 (12.4) 27.5 (11.5) 28.1 (13.9) 35.7 (8.7) 33.2 (11.2)
Symptom onset to first household visit -
mean ± SD:
< 36 h 6/13 (46) 5/11 (46) 9/17 (52) 4/17 (24) 1/15 (7) 1/11 (9)
36-48 h 4/13 (31) 2/11 (18) 4/17 (24) 9/17 (52) 7/15 (47) 6/55 (55)
48-60 h 3/13 (23) 4/11 (36) 4/17 (24) 0 2/15 (13) 1/11 (9)
> 60 h 0 0 0 4/17 (24) 5/15 (33) 3/11 (27)
Household size - mean ± SD 3.8 (1.2) 3.8 (1.2) 2.2 (1.1) 3.9 (1.3) 3.5 (0.9) 3.7 (1.1)
Household Contacts - n 36 31 39 46 38 28
Age (years) - median (IQR) 35 (18-40) 37 (12-43) 34 (19-42) 38 (12-43) 35(17-42) 35 (15-43)
Age < 14 years - n/n (%) 6/36 (17) 8/31 (26) 6/39 (15) 13/46 (28) 8/38 (21) 6/28 (21)
Sex male - n/n (%) 18/36 (50) 15/31 (49) 17/39 (44) 21/46 (46) 19/38 (50) 16/28 (57)
Vaccinated* - n/n (%) 0 1/31 (3) 1/39 (3) 6/46 (13) 7/38 (18) 1/28 (4)
Chronic Illness - n/n (%) 3/35 (9) 2/27 (7) 3/37 (8) 13/46 (28) 8/38 (21) 3/28 (11)
IQR Inter-Quartile-Range, SD Standard deviation. * Vaccination defined as vaccination against pandemic influenza in the pandemic season 2009/10 and trivalent
seasonal vaccine in 2010/11, at least 14 days before symptom onset in index patient. ** Antiviral therapy defined as treatment with oseltamivir or zanamivir
within 2 days of symptom onset
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The amount of remaining intervention material was
assessed at the end of the study periods. Participants in
the M group used a median of 12.9 (interquartile range
[IQR]: 9.5-16) facemasks per individual, members of the
MH group used a median of 12.6 (IQR: 7.8-14). There
was no statistically significant difference between the
seasons (data not shown). Only in 2010/11 did we assess
the mean number of facemasks used per day and indivi-
dual: participants in the M group used a mean number
of 1.8 (SD: 1.8) and those in the MH group 1.7 (SD: 2.0)
facemasks per day. The mean amount of alcohol based
hand rub used over the study period by individuals in
the MH group was higher in 2009/10 compared to
2010/11 (85.2 ml vs. 42.7 ml, p = 0.2).
Facemasks
We used two definitions to describe adherence to wear-
ing masks. The first evaluated daily adherence and con-
sidered a participant as “adherent” if they wore a mask
“always” or “mostly” on each day as required by the
study protocol (adherence definition 1). The second
definition evaluated behaviour of participants during the
first 5 days after implementation of the intervention [6].
A participant was termed adherent if they wore a face-
mask “always” or “mostly” on each of the first 5 days
after full implementation of the intervention (adherence
definition 2). Figures 2 and 3 display the data for adher-
ence (according to definition 1) to facemask use in the
M and MH group separately for index patients (Figure
2) and household contacts (Figure 3).
In general, daily adherence was good, reaching a pla-
teau of over 50% in nearly all groups (M and MH
groups; 2009/10 and 2010/11) from the third day on (by
then the intervention had been implemented in all
households). A gradual decline towards lower adherence
began around the sixth day of the index patient’s illness.
A further observation was that in 2010/11 MH index
patients were less adherent than M index patients (Fig-
ure 2, right panel; difference not statistically significant)
w h i l et h et w og r o u p sw e r ef a i r l ys i m i l a rd u r i n gt h e
2009/10 pandemic. Similar differences can be observed
when only the first 5 days following full study imple-
mentation were considered (definition 2) (Table 6).
Adherence behaviour of household contacts was similar
in both seasons.
In both season, the majority of participants (107/172,
6 2 % )d i dn o tr e p o r ta n yp r o b l e m sw i t hm a s kw e a r i n g .
This proportion was significantly higher in the group of
adults (71/100, 71%) compared to the group of children
(36/72, 50%) (p = 0.005). The main problem stated by
participants (adults as well as children) was “heat/
humidity” (18/34, 53% of children; 10/29, 35% of adults)
(p = 0.1), followed by “pain” and “shortness of breath”
when wearing a facemask.
Hand hygiene
For the daily evaluation of adherence to hand hygiene
measures we used the number of hand disinfections as
indicated by MH participants (adherence definition 1).
A MH participant was termed adherent according to
definition 2 if they had disinfected their hands at least
Table 2 Secondary attack ratios of qRT-PCR confirmed influenza infection and clinical influenza, intention-to-treat
analysis
Confirmation of
influenza infection
Control Group Mask Group Mask & Hygiene
Group
p-value
§
n/n SAR
(95% CI
#)
n/n SAR
(95% CI
#)
n/n SAR
(95% CI
#)
RT-PCR* All cases 19/82 23 (13-35) 6/69 9 (3-19) 10/67 15 (5-27) 0.18
Influenza A (H1N1) pdm09 13/56 23 (11-37) 6/58 10 (3-20) 4/50 8 (2-17) 0.16
Influenza B 6/26 23 (5-48) 0/11 0 6/17 35 (7-60) 0.22
Season 2009/2010 8/36 22 (10-35) 3/31 10 (0-26) 3/39 8 (0-18) 0.29
Season 2010/2011 11/46 24 (9-42) 3/38 8 (0-19) 7/28 25 (4-45) 0.27
Implementation of intervention
<3 6hafter symptom onset of index patient
5/22 23 (6-39) 1/14 7 (0-23) 1/24 4 (0-16) 0.17
Clinical (ILI**) All cases 14/82 17 (7-29) 6/69 9 (3-17) 6/67 9 (3-16) 0.37
Influenza A (H1N1) pdm09 10/56 18 (7-31) 6/58 10 (3-20) 3/50 6 (0-13) 0.29
Influenza B 4/26 15 (0-39) 0/11 0 3/17 18 (0-37) 0.56
Season 2009/2010 6/36 17 (6-31) 4/31 13 (3-30) 3/39 8 (0-16) 0.57
Season 2010/2011 8/46 17 (2-35) 2/38 5 (0-14) 3/28 11 (0-25) 0.48
Implementation of intervention <3 6hafter
symptom onset of index patient
4/22 18 (4-38) 2/14 14 (0-36) 1/24 4 (0-13) 0.41
*RT-PCR Real time polymerase chain reaction. **ILI Influenza-like-illness.
§p-values adjusted for cluster design of the study
#95% CI 95% confidence interval. Confidence intervals were calculated using bootstrapping methods
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Page 7 of 16five times per day on each of the 5 days after full imple-
mentation of the intervention. Similar to the low face-
mask adherence of MH index patients in 2010/11, this
group also displayed low hand hygiene adherence com-
pared to the index patients of 2009/10. As in facemask
adherence, household contacts kept a relatively stable
level of adherence in both seasons (Figure 4). Also the
5-day adherence (adherence definition 2) of index
patients of the MH group dropped from 41% in 2009/10
to 18% in 2010/11 (p = 0.2) while it did not drop in
household contacts (Table 6).
We validated reported data on adherence by comparing
the indicated number of daily mask use and number of
disinfections with the remaining intervention material in
each household at the end of the study period. For both
interventions, cumulative subjective information by parti-
cipants correlated well with the objective measurements
of the remaining material (facemasks: r = 0.64, p < 0.001
(only possible for season 2010/11 as information on the
number of facemasks used per day was only collected in
the season 2010/11); hand hygiene: r = 0.53, p < 0.001).
We observed “contamination” between intervention
groups in two control households only in the season
2009/10, one reported wearing masks, the other reported
wearing masks and using alcohol based hand sanitizer.
Examination of further potentially relevant behavioural
variables, such as daily time spent at home during the
study period, time spent at close range of the index
patient, sleeping in the same room or taking meals with
the index patient, did not result in significant differences
between the study groups or between influenza seasons
(data not shown).
Discussion
We present results of a cluster randomised trial on the
effectiveness of facemasks and hand hygiene in prevent-
ing household transmission of influenza. The trial was
conducted in Berlin during the first two seasons after
the onset of the influenza A (H1N1)pdm09 pandemic.
In primary intention-to-treat analysis of all data, the
interventions did not lead to statistically significant
reductions of SAR in household contacts. However, in a
Table 3 Separate models for predictors of qRT-PCR confirmed influenza infection and clinical influenza among
included households.
Variable RT-PCR confirmed Influenza ILI
OR 95% CI p-value OR 95% CI p-value
Intervention Group
Control Group Ref. Ref.
Mask Group 0.39 0.13-1.19 0.10 0.56 0.18-1.68 0.3
Mask & Hygiene Group 0.61 0.23-1.66 0.34 0.47 0.15-1.49 0.2
Intervention Groups combined
Control Group Ref. Ref.
Mask Group +
Mask & Hygiene Group
0.50 0.21-1.20 0.12 0.51 0.2-1.28 0.15
Sex*
Female Ref. Ref.
Male 1.2 0.62-2.28 0.52 0.65 0.3-1.42 0.28
Age*
Adult (> 14 yrs) Ref. Ref.
Child 1.52 0.71-3.23 0.28 2.22 0.97-5.08 0.06
Time spent at home*
< 18 hours/day Ref. Ref.
≥18 hours/day 3.1 1.3-7.33 0.01 3.98 1.34-11.77 0.01
Therapy of Index patient*
No timely therapy Ref. Ref.
Timely therapy 1.63 0.70-3.81 0.26 1.07 0.42-2.7 0.89
Vaccination of Contact*
No vaccination Ref. Ref.
Vaccination 0.62 0.11-3.56 0.6 0.48 0.06-3.94 0.49
Independent variables: (i) intervention group, (ii) intervention group (with pooled data of Mask- and Mask&Hygiene group), (iii) one separate model for each
individual variable that may influence household transmission of influenza (i.e. age, sex, timely antiviral therapy of the index, vaccination of household contacts)
adjusted for intervention group
OR Odds ratio, 95% CI 95% Confidence Interval
*Models also included intervention group as independent variable
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Page 8 of 16secondary analysis among households with full imple-
mentation of the intervention within 36 h after symp-
tom onset, the combined participants from M and MH
groups had a significantly lower chance of influenza
infection compared to controls. With one exception
(MH households in 2010/11), we observed a non-signifi-
cant, but consistent and substantial reduction of the OR
for influenza infection in both intervention groups (M,
MH) and for both case definitions (laboratory confirmed
and clinical).
Table 4 Multivariable analysis for predictors of qRT-PCR confirmed influenza infection and clinical influenza among
included households in separate models allowing for within household correlation.
Variable RT-PCR confirmed Influenza ILI
OR 95% CI p-value OR 95% CI p-value
Complete
Data
Intervention Group*
Control Group Ref. Ref.
Mask Group 0.39 0.13-1.17 0.09 0.61 0.2-1.87 0.39
Mask & Hygiene Group 0.62 0.23-1.65 0.34 0.50 0.16-1.58 0.24
Intervention Groups combined*
Control Group Ref. Ref.
Mask Group +
Mask & Hygiene Group
0.50 0.21-1.19 0.12 0.55 0.22-1.40 0.21
2009/2010 Intervention Group*
Control Group Ref. Ref.
Mask Group 0.34 0.07-1.76 0.20 0.74 0.17-3.2 0.68
Mask & Hygiene Group 0.23 0.05-1.13 0.07 0.41 0.09-1.84 0.24
Intervention Groups combined*
Control Group Ref. Ref.
Mask Group +
Mask & Hygiene Group
0.28 0.08-1.05 0.06 0.54 0.16-1.85 0.32
2010/2011 Intervention Group*
Control Group Ref. Ref.
Mask Group 0.35 0.07-1.63 0.18 0.37 0.06-2.35 0.3
Mask & Hygiene Group 1.0 0.26-3.78 1.0 0.55 0.09-3.44 0.5
Intervention Groups combined*
Control Group Ref. Ref.
Mask & Hygiene Group 0.63 0.19-2.11 0.45 0.45*** 0.1-2.0 0.3
Implementation
of intervention
< 36 h after
symptom onset
Intervention Group**
Control Group Ref. Ref.
Mask Group 0.21 0.02-2.02 0.18 0.63 0.08-4.92 0.66
Mask & Hygiene Group 0.13 0.01-1.28 0.08 0.17 0.01-2.03 0.16
Intervention Groups combined**
Control Group Ref. Ref.
Mask Group +
Mask & Hygiene Group
0.16 0.03-0.92 0.04 0.34 0.06-2.13 0.25
Only A/H1N1 pdm09 Infection Intervention Group*
Control Group Ref. Ref.
Mask Group 0.37 0.12-1.19 0.10 0.55 0.17-1.84 0.33
Mask & Hygiene Group 0.27 0.07-0.99 0.049 0.26 0.06-1.15 0.08
Intervention Groups combined*
Control Group Ref. Ref.
Mask Group +
Mask & Hygiene Group
0.33 0.12-0.88 0.027 0.41 0.14-1.19 0.1
Intention-to-treat analysis. (n = 216 household contacts)
OR Odds ratio, 95% CI 95% Confidence Interval. * adjusted for age, sex, timely therapy of the index, vaccination of household contacts, time spent at home. **
adjusted for age, sex, timely therapy of the index, time spent at home. *** adjusted for age and sex
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Page 9 of 16Table 5 Multivariable analysis for predictors of qRT-PCR confirmed influenza infection and clinical influenza among
included households in separate models allowing for within household correlation.
Variable RT-PCR confirmed Influenza ILI
OR 95% CI p-value OR 95% CI p-value
Complete
Data
Intervention Group*
Control Group Ref. Ref.
Mask Group 0.3 0.1-0.94 0.04 0.5 0.2-1.6 0.3
Mask & Hygiene Group 0.59 0.2-1.5 0.3 0.49 0.2-1.6 0.2
Intervention Groups combined*
Control Group Ref. Ref.
Mask Group +
Mask & Hygiene Group
0.45 0.2-1.1 0.07 0.5 0.2-1.3 0.2
2009/2010 Intervention Group*
Control Group Ref. Ref.
Mask Group 0.21 0.03-1.4 0.1 0.7 0.13-3.4 0.6
Mask & Hygiene Group 0.21 0.04-1.09 0.06 0.5 0.09-2.2 0.3
Intervention Groups combined*
Control Group Ref. Ref.
Mask Group +
Mask & Hygiene Group
0.21 0.05-0.9 0.04 0.53 0.14-2.08 0.4
2010/2011 Intervention Group*
Control Group Ref. Ref.
Mask Group 0.32 0.07-1.49 0.15 0.4 0.06-2.3 0.3
Mask & Hygiene Group 0.94 0.25-3.5 0.9 0.51 0.09-3.3 0.5
Intervention Groups combined*
Control Group Ref. Ref.
Mask Group +
Mask & Hygiene Group
0.6 0.2-2.0 0.4 0.4 0.1-1.9 0.3
Implementation
of intervention
< 36 h after
symptom onset
Intervention Group**
Control Group Ref. Ref.
Mask Group 0.23 0.02-3.02 0.26 0.7 0.07-7.9 0.8
Mask & Hygiene Group 0.21 0.02-2.33 0.2 0.2 0.01-3.4 0.3
Intervention Groups combined**
Control Group Ref. Ref.
Mask Group +
Mask & Hygiene Group
0.22 0.03-1.6 0.1 0.4 0.05-3.3 0.4
Only A/H1N1 pdm09 Infection Intervention Group*
Control Group Ref. Ref.
Mask Group 0.28 0.08-0.97 0.04 0.46 0.1-1.7 0.2
Mask & Hygiene Group 0.26 0.07-0.93 0.04 0.26 0.06-1.17 0.08
Intervention Groups combined*
Control Group Ref. Ref.
Mask Group +
Mask & Hygiene Group
0.27 0.1-0.76 0.01 0.36 0.1-1.1 0.08
Per-protocol analysis. (n = 216 household contacts)
OR Odds ratio, 95% CI 95% Confidence Interval. * adjusted for age, sex, timely therapy of the index, vaccination of household contacts, time spent at home. **
adjusted for age, sex, timely therapy of the index, time spent at home
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Page 10 of 16Figure 2 Facemask adherence by index patients. Daily proportion and 95% confidence interval of index patients wearing a facemask ‘always’
or ‘mostly’ in transmission-prone situations, in households assigned to wearing facemasks and practising intensified hand hygiene (MH group;
dashed line) or to only wearing facemasks (M group; continuous line), stratified by season. Symbols represent the proportion of participants
wearing facemasks before (green, hollow circles) and after (black squares) the intervention was fully implemented in the household.
Figure 3 Facemask adherence by household contacts. Daily proportion and 95% confidence interval of household contacts wearing a
facemask ‘always’ or ‘mostly’ in transmission-prone situations, in households assigned to wearing facemasks and practising intensified hand
hygiene (MH group; dashed line) or only wearing facemasks (M group; continuous line), stratified by season. Symbols represent the proportion of
participants wearing facemasks before (green, hollow circles) and after (black squares) the intervention was fully implemented in the household.
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Page 11 of 16A per-protocol analysis showed comparable results of
lowered influenza transmission in the intervention
groups which were statistically significant in the M
group when analysing the complete dataset, and -
among A (H1N1) pdm09 households - in the combined
analysis of the M and MH groups. The main drawback
of the study was that we did not reach the number of
households that we had aimed and planned for, one of
the reasons being the at best moderate influenza sea-
son 2010/11. Our sample size calculation was based on
a 75% reduction of risk due to the interventions. This
may seem questionably high in comparison to other
studies, however based on experience from our pilot
study we felt that adherence would be better than
reported in the Hong Kong [5] and Bangkok [7] stu-
dies. We therefore expected a larger effect size in our
main study.
The reason for the high SAR of 25% in MH households
from the 2010/11 season (with 35% the SAR was even
higher when only households with Influenza-B positive
index patients were considered) remains unclear. How-
ever, we hypothesize that the particularly low adherence
of MH index patients to both interventions during the
2010/11 season might have influenced this observation.
The fact that we observed a significant effect of the
combined M and MH intervention only after restriction
of analysis to households with early (< 36 h after symp-
tom onset) implementation of the interventions is in
agreement with Cowling et al. who had investigated a
hand hygiene intervention as well as hand hygiene plus
facemask use [5]. The importance of early implementa-
tion of any intervention is plausible given high levels of
viral shedding during the initial period of influenza
infection [20] as well as the short incubation period
[21]. Recently, Donnelly et al. quantified the probability
of a transmission event by an infectious person relative
to the onset of symptoms [22] and showed that peak
transmission occurred on days 1, 2 and 3 of the infec-
tious patient’s illness. Merely 18% of transmission events
took place more than two days after symptom onset of
the index patient.
An Australian cluster-randomized household study
conducted in a pre-pandemic winter season investigated
the effect of the use of facemasks (surgical, or N95) on
Table 6 Adherence to interventions in index patients and household contacts by intervention group and study season
Variables Index Contacts
Mask Group Mask & Hygiene
Group
Mask Group Mask & Hygiene
Group
2009/
2010
2010/
2011
2009/
2010
2010/
2011
2009/
2010
2010/
2011
2009/
2010
2010/
2011
Hygiene variables
Number of hand disinfections per day - mean ± SD NA 7.4
(6.3-8.5)*
4.1
(3.3-4.8)*
NA 8.8
(7.9-9.6)
7.5
(6.5-8.5)
Adherent to intensified hand hygiene during each of
the five days after implementation of the intervention
(adherence def. 2) - n/n (%)**
NA 8/17
(47)*
1/9
(9)*
NA 15/39
(38)
13/28
(46)
Hand disinfection/-washing after coming home*** - n/
n (%)
7/9
(78)
7/14
(50)
10/16
(63)
6/11
(55)
11/23
#
(64)
21/30
#
(70)
28/32
#
(88)
20/22
#
(91)
Hand disinfection/-washing after touching
contaminated objects*** - n/n (%)
1/11
(9)
0 3/17
(18)
1/11
(9)
11/23
#
(48)
16/30
#
(53)
28/32
#
(88)
16/22
#
(73)
Hand disinfection/-washing before eating*** - n/n (%) 8/11
(73)
6/15
(40)
13/17
(77)
6/11
(55)
23/23
#
(100)
27/30
#
(90)
28/32
#
(88)
15/22
#
(68)
Hand disinfection/-washing after coughing/sneezing***
- n/n (%)
5/11
(46)
0 9/17
(53)
3/11
(27)
17/30
#
(57)
16/38
#
(42)
22/38
#
(58)
8/28
#
(29)
Mask variables
Adherent to facemask use during each of the five days
after full implementation of the intervention
(adherence definition 2) - n/n (%)
##
6/11
(55)
7/15
(47)
7/17
(41)
2/11
(18)
17/31
(55)
18/39
(46)
17/38
(45)
13/28
(46)
Wore facemask when being in the same room with
index/contact*** - n/n (%)
8/10
(80)
8/15
(53)
13/16
(81)
6/11
(55)
23/31
(74)
32/37
(87)
26/38
(68)
24/28
(86)
Wore facemask when being in close contact to index/
contact*** - n/n (%)
7/10
(70)
9/15
(60)
13/16
(81)
5/11
(46)
24/31
(77)
34/38
(90)
27/38
(71)
21/28
(75)
Wore facemask when providing care to index/being
provided for by household contact*** - n/n(%)
6/9
(67)
4/5
(80)
6/12
(50)
3/7
(43)
10/16
(63)
13/16
(81)
12/21
(57)
12/13
(92)
NA not applicable, HD hand disinfection, SD standard deviation. * p < 0.05 between seasons. ** Adherence to hand hygiene measure was defined as disinfection
of hands at least 5 times per day during the 5 day after full implementation of the intervention (based on data from daily questionnaire). *** based on data from
exit questionnaire. #only adults. ## Adherence to facemask intervention was defined as wearing a facemask “mostly” or “always” on each of the 5 days after full
implementation of the intervention (based on data from daily questionnaire)
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Page 12 of 16the risk of respiratory infections with all index cases
being children and having an influenza-like illness of
any, even unknown, etiology [6]. Intention-to-treat ana-
lysis did not yield significant results, however, good
adherence to facemask use proved to be significantly
protective in a per-protocol analysis.
Two further cluster-randomized household studies
failed to see any significant effects of intervention mea-
s u r e s( f a c e m a s k so rh a n dh y g i e n e )e v e ni ns e c o n d a r y
analyses. A French study investigated the efficacy of
facemasks in the pre-pandemic influenza season 2008/
09 [4]. Although a planned second season was not fol-
lowed through due to the onset of the influenza A
(H1N1)pdm09 pandemic, reported SAR after the first
season were quite similar in intervention and control
groups. Adherence was reported to be good, but only a
clinical case definition (ILI) was used for secondary
cases, thus probably missing a- and oligosymptomatic
secondary cases. Only index patients were supposed to
wear the masks, and mean age of index patients in the
intervention arm was 25 years. Since young children
and infants may play a more important role in the
(household) transmission of influenza [23-25], it is pos-
sible that these factors may have led to a cumulative
underestimation of the real effect of facemasks.
The second study failing to see an effect of NPI in the
household setting comes from Bangkok, Thailand and
was conducted between April 2008 and August 2009
[7]. Interventions tested were facemasks combined with
handwashing, and handwashing alone. Although study
size was large corresponding to high statistical power,
the fact that 90% of index patients slept in the same
bedroom as their parents without wearing facemasks
during the night may have overcome any protective
effect conferred by the interventions during daytime. In
addition, authors describe a considerable amount of
contamination between intervention groups, which may
have further concealed true effects of the interventions.
In our study adherence to both interventions was
good. After full implementation of the interventions
approximately 50% of M and MH participants (index
and contacts) wore facemasks “mostly” or “always” dur-
ing the daytime in situations as required by the study
protocol, and MH participants disinfected their hands
approximately 7-8 times per day; only MH index cases
in 2010/11 had lower adherence values for both inter-
ventions. Comparison with other studies is difficult for a
number of reasons, particularly because interventions
differed. Cowling [5] defined facemask adherence similar
to the present study and reported similar facemask
Figure 4 Adherence to hand hygiene measures by index patients and household contacts. Frequency of daily hand disinfection (mean,
standard deviation) in participants assigned to the MH group, stratified by season. Symbols represent the mean frequency of hand disinfection
before (green, hollow circles) and after (black squares) the intervention was fully implemented in the households. Data of index patients are
depicted by a continuous line, data of household contacts by a dashed line.
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Page 13 of 16adherence in index cases (49%), but worse in household
contacts (26%). Adherence to wearing facemasks in the
Canini [4] study can be compared to our study for
2010/11, because the number of facemasks used per day
was measured only in this season. The results were
comparable in both studies.
Hand hygiene was part of the trial design only in the
Simmermann [7] and Cowling studies [5]. MH index
patients in our study disinfected their hands between
4.1 (2010/11) and 7.4 times (2009/10) per day, the index
patients in the Simmerman study washed their hands
4.1 times per day. Adherence to hand disinfection by
index patients over the course of the study (adherence
definition 2) ranged between 9% (2010/11) and 47%
(2009/10) in our trial, compared to Cowling et al. with
33% and 36% in the two groups assigned hand hygiene
interventions. Among household contacts in the MH
group of our study adherence was higher in every para-
meter measured compared to Simmerman et al. and
Cowling et al.. Considering that facemask and perhaps
also disinfectant use in household settings may be much
less accepted in European compared to Asian countries
[26], the high overall adherence of both interventions in
our study is remarkable. However, adherence data in all
studies were based on self reporting and differences in
reporting behaviour may have influenced results.
Compared to 2010/11 adherence may have been higher
during the pandemic season 2009/10, but differences
were not statistically significant. Increased use of or will-
ingness to use preventive measures, such as facemasks or
hand hygiene, was also documented during the SARS epi-
demic as well as during the pandemic influenza A
(H1N1)pdm09 [27-29]. As we reported previously [9],
adherence was good in adults and children alike, and
although difficulties with facemasks were more frequently
reported by children compared to adults, the numbers
were not high. One notable exception with considerably
lower adherence in 2010/11 compared to 2009/10 was
observed in index patients of the MH group. Because
physical interventions used by infected children may have
the largest effect on the reduction of spread [30] and
most index cases were children, it is possible that their
reduced adherence has negatively affected transmission
rates in MH households resulting in higher SAR in this
intervention group in 2010/11.
In general, we believe that our data for adherence and
tolerability would support a recommendation to use
non-pharmaceutical interventions in a pandemic.
Several limitations may have influenced the results of
this study. As in all previous studies on this subject, our
study design resulted in delays between symptom onset
of the index patients and implementation of the inter-
vention. This delay could be as long as 3 days in some
households during the 2010/11 season. Although we
tried to address this problem by calling the households
for preliminary instructions directly after enrolment at
their physicians’ office, this does not substitute for a
personal visit with a demonstration of the intervention
in the household. This may have led to an underestima-
tion of the true effect of the interventions.
A further limitation of our s t u d yi st h a tw ec a n n o t
determine whether a possible protective effect of wear-
ing facemasks is more attributable to their use by index
patients or by household contacts (or both), nor can we
say if intensified hand hygiene provides any additional
protection. Regarding the first question, there are data
from a Dutch experimental study suggesting that the
u s eo fm a s k sm a yb em o r ee f f e c t i v ef o ri n w a r dt h a nf o r
outward protection which would favour the importance
of healthy persons wearing them [31]. This is in line
with the results of the French trial [4] which stated in
its protocol that facemasks were only to be worn by
index patients and which could not show any significant
protective effect in this setting. Regarding the role of
hand hygiene, existing data from clinical trials are
inconclusive. The study from Thailand found no effect,
neither for facemasks nor for hand hygiene [7]. In the
analysis of households where the intervention was
applied within 36 h the Hong Kong study saw a (non-
significant) effect of hand hygiene alone which became
stronger and significant in the MH arm [5]. The investi-
gators of a study among university students observed
comparable reductions in ILI both in the facemask only
as well as the facemasks plus hand hygiene groups sug-
gesting that the addition of a hand sanitizer did not
increase the effect of facemasks, or at least not substan-
tially [3]. Nevertheless, a recent Cochrane review on the
subject came to the conclusion that hand hygiene is
generally effective in reducing the spread of respiratory
viruses [30].
A further limitation is the fact that laboratory testing
of household contacts was only conducted for the virus
subtype the index patient was infected with. This could
have led to an underestimation of secondary cases.
Finally, we cannot rule out the possibility that beha-
viour of participating households may have been influ-
enced by monetary incentives and frequent household
visits. However, they did not differ in all three study
a r m ss ow ed on o te x p e c tt h i st oh a v eb i a s e do u r
results. Furthermore, the other clinical trials had a simi-
lar design so that it should not endanger comparability
of results.
The strengths of this study include laboratory confir-
mation of primary and secondary cases with qRT-PCR,
the serial testing of all household members over the
study period irrespective of respiratory symptoms, and
the low degree of contamination between the interven-
tion groups.
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In conclusion, results of our study contribute to the
b o d yo fe v i d e n c et h a tN P Im a yb ee f f e c t i v ei np r e v e n t -
ing transmission of influenza in households. Prerequi-
sites include early implementation of the intervention
and good adherence.
We were also able to show that the use of facemasks
in particular is tolerable and acceptable for adults and
children alike, both as household contacts and index
cases, highlighting the fact that these measures could
play an important role in the interruption of influenza
transmission within households. Future research should
focus on the differential importance of facemask use by
index cases or household contacts as well as the inde-
pendent role of hand hygiene in the prevention of influ-
enza transmission.
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